Equities

Lyra Therapeutics Inc

LYRA:NMQ

Lyra Therapeutics Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.1796
  • Today's Change0.002 / 0.90%
  • Shares traded2.86m
  • 1 Year change-94.24%
  • Beta-0.1025
Data delayed at least 15 minutes, as of Nov 21 2024 20:51 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, cash reserves at Lyra Therapeutics Inc fell by 10.20m. Cash Flow from Financing totalled 65.69m or 4,216.37% of revenues. In addition the company used 63.30m for operations while cash used for investing totalled 12.58m.
Cash flow per share-1.52
Price/Cash flow per share--
Book value per share0.315
Tangible book value per share0.315
More ▼

Balance sheet in USDView more

Lyra Therapeutics Inc uses little or no debt in its capital structure.
Current ratio3.64
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.